First Stage Investor

Startup Insider: 20/20 GeneSystems Pivots, Builds New Partnership

Startup Insider: 20/20 GeneSystems Pivots, Builds New Partnership
By Early Investing
Date September 19, 2022
Share
20/20 GeneSystems has been busy. We first recommended the company in December 2017 when we learned about its incredible cancer detection technology. 20/20 GeneSystems identifies cancer risk early on by using tumor antigen markers. It can improve cancer detection by up to 30%…
Early Investing

First Stage Investor

Sign up to view this First Stage Investor article

Become a smarter investor! Discover new investment opportunities and get the latest market research, trends and analysis in startups, crypto and cannabis.

Sign up today

Top Posts on Early Investing

Crypto Monitor: A Victory for Crypto in China and Hong Kong

China has a complicated relationship with crypto. The Chinese government continues to promote the use and development of blockchain, but crypto trading is still banned in mainland China.…

Bitcoin Decouples From Stocks, Moves Closer to Gold

Crypto Market Musings It’s been a relatively calm week for crypto. Bitcoin is up 1.73% over the last seven days as of this writing. Ethereum is up 3.54%…

New Pick: A Hidden Treasure in the Plant-Based Meat Market

Editor’s Note: This recommendation was co-authored by KingsCrowd Investment Research Manager Olivia Strobl. Mmmm, pizza.